Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2019-08-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-019-03006-xPMID 31428933PMCID PMC11810172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival Patterns for Patients with Resected N2 Non–Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach

  2018cited by this paper
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2018cited by this paper
• Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small cell lung cancer: a monocentric clinical study.

  2018cited by this paper
• N2 lung cancer is not all the same: an analysis of different prognostic groups.

  2018cited by this paper
• Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease.

  2018cited by this paper
• Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer

  2017cited by this paper
• Targeting Lung Cancer Stem Cells: Research and Clinical Impacts

  2017cited by this paper
• Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer

  2017cited by this paper
• Upfront surgery as first‐line therapy in selected patients with stage IIIA non–small cell lung cancer

  2017cited by this paper
• Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer

  2016cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

  2016cited by this paper
• Lymph node metastasis according to primary tumor location in T1 and T2 stage non‐small cell lung cancer patients

  2016cited by this paper
• Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases.

  2016cited by this paper
• Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer

  2016cited by this paper
• Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer

  2015cited by this paper
• Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer

  2015cited by this paper
• [A clinical prediction model for N2 lymph node metastasis in clinical stage I non-small cell lung cancer].

  2015cited by this paper
• Modern outcome and risk analysis of surgically resected occult N2 non-small cell lung cancer.

  2014cited by this paper
• Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer.

  2014cited by this paper
• Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection

  2012cited by this paper
• A prediction model for N2 disease in T1 non-small cell lung cancer.

  2012cited by this paper
• Is limited resection appropriate for radiologically "solid" tumors in small lung cancers?

  2012cited by this paper
• Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?

  2011cited by this paper
• Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

  2010cited by this paper
• N2 disease in T1 non-small cell lung cancer.

  2009cited by this paper
• Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.

  2007cited by this paper
• Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.

  2006cited by this paper
• Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.

  2005cited by this paper
• Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.

  2005cited by this paper
• Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.

  2004cited by this paper
• Tumor size predicts survival within stage IA non-small cell lung cancer.

  2003cited by this paper
• Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?

  1996cited by this paper
• T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT.

  1993cited by this paper
• Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter.

  1990cited by this paper

• Patterns and risk factors of lymph node metastasis in non-small cell lung cancer 2 cm or less

  2026cites this paper
• Risk factors and predictive model of lymph node metastasis in clinical stage IA peripheral non-small cell lung cancer: a retrospective study

  2025cites this paper
• Radiomics models for predicting occult nodal metastasis in stage cT1a-bN0M0 lung adenocarcinoma: a multicenter study

  2025cites this paper
• Correlation Between the Number of Pathological Risk Factors and Postoperative Prognosis in Patients with Stage I Lung Adenocarcinoma

  2024cites this paper
• Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies

  2024cites this paper
• Lymphatic vascular invasion: Diagnostic variability and overall survival impact on patients undergoing surgical resection

  2024cites this paper
• Lymph node metastasis and its risk factors in T1 lung adenocarcinoma

  2023cites this paper
• Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter

  2022cites this paper
• Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC

  2022cites this paper
• The effect of refined nursing applied in the nursing room of thoracoscopic lung cancer radical operation in Southwestern China

  2021cites this paper
• Risk analysis in peripheral clinical T1 non-small cell lung cancer correlations between tumor-to-blood standardized uptake ratio on 18F-FDG PET-CT and primary tumor pathological invasiveness: a real-world observational study.

  2021cites this paper
• Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery

  2021cites this paper
• Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer

  2020cites this paper
• Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease.

  2018cites this paper